☆ 4.7 Article

Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study

CRITICAL CARE (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States

Hunter B. Moore

Summary: Low fibrinolytic activity is associated with pathological thrombosis and multiple-organ failure. There are two commonly associated terms, hypofibrinolysis and fibrinolysis shutdown, to describe this condition. However, these terms are often used interchangeably in describing critically ill patients, leading to confusion in understanding the underlying disease processes. The lack of research on the cellular mediators of these processes further complicates the issue. This article aims to review the mechanisms of fibrinolysis in the context of low fibrinolytic states and emphasize the importance of differentiating hypofibrinolysis from fibrinolysis shutdown.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Add to Collection

Article Anesthesiology

Temporal Transitions in Fibrinolysis after Trauma: Adverse Outcome Is Principally Related to Late Hypofibrinolysis

Andrea Rossetto et al.

Summary: The study identified an association between low maximum lysis within 24 hours and adverse outcomes in trauma patients, with tranexamic acid modifying early fibrinolysis patterns and reducing early mortality. Late mortality was not increased in patients with low maximum lysis at 24 hours, suggesting that adverse late outcomes are more closely related to 24-hour maximum lysis regardless of admission levels.

ANESTHESIOLOGY (2022)

Add to Collection

Article Critical Care Medicine

Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19 A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial

Christopher D. Barrett et al.

Summary: This study investigated the effects of tissue plasminogen activator (tPA) on pulmonary function in severe COVID-19 respiratory failure. The results showed significant improvement in lung oxygenation in the tPA bolus group compared to the control group. However, there were no statistically significant differences in the improvement of PaO2/FIO2 ratio, composite outcome, ventilator-free days, and in-hospital mortality between the tPA bolus group and the control group.

CHEST (2022)

Add to Collection

Article Hematology

The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1

Claire S. Whyte et al.

Summary: This study investigates the dysregulation of the fibrinolytic system in COVID-19 disease and finds that elevated levels of PAI-1 suppress plasmin generation, leading to suboptimal fibrinolysis. These findings have important implications for the treatment and prognostic potential of COVID-19 disease.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Multidisciplinary Sciences

A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study

Ryogo Yoshii et al.

Summary: This study compared the ClotPro system with ROTEM and plasma coagulation assays in cardiac surgery patients. The results showed a strong correlation between ClotPro and ROTEM, with EX-test and IN-test parameters being interchangeable. ClotPro was capable of emulating well-established ROTEM thresholds, providing a new tool for assessing hemostasis.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Anesthesiology

Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients

Christoph Heinz et al.

Summary: The study found significant changes in clot formation and lysis in COVID-19 patients, particularly in increased fibrin contribution to maximum clot firmness and prolongation of lysis time. These findings may contribute to our understanding of the hypercoagulable state in critically ill patients with COVID-19.

ANESTHESIOLOGY (2021)

Add to Collection

Article Hematology

Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series

Patricia Duque et al.

Summary: Using ClotPro technology, two viscoelastic assays were conducted in critically ill and noncritically ill patients with coronavirus disease 2019, revealing a marked hypercoagulability and increased resistance to fibrinolysis. Pathological observations suggest that this hypercoagulative status may be, to some extent, due to fibrinolysis shutdown.

BLOOD COAGULATION & FIBRINOLYSIS (2021)

Add to Collection

Article Anesthesiology

Impaired fibrinolysis in critically ill COVID-19 patients

Mirjam Bachler et al.

Summary: Critically ill COVID-19 patients exhibit a hypercoagulable state with impaired fibrinolysis, characterized by increased clot firmness and decreased fibrinolytic response in whole blood coagulation tests. This hypofibrinolytic state may be at least partially due to a decreased fibrinolytic response.

BRITISH JOURNAL OF ANAESTHESIA (2021)

Add to Collection

Article Multidisciplinary Sciences

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Yu Zuo et al.

Summary: COVID-19 patients have elevated levels of tPA and PAI-1 in plasma, which are correlated with neutrophil counts and respiratory status. Particularly high levels of tPA are strongly associated with mortality and enhanced fibrinolysis, suggesting a subset of patients may have a favorable balance of factors for fibrinolysis. Further investigation into tPA as a biomarker is warranted.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Hematology

Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19

Stefanie Hammer et al.

Summary: This study found that COVID-19 patients have impaired fibrinolytic activity in the blood. Compared with healthy controls, significant abnormalities in clotting and fibrinolysis markers were observed in ICU COVID-19 patients.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Hematology

Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients

Kristina Boss et al.

Summary: The ROTEM analysis revealed significantly different pathological findings characterized by hypercoagulability and fibrinolysis shutdown among COVID-19 patients with a severe disease course compared to patients with severe sepsis, indicating a higher risk of thromboembolic events in COVID-19 patients.

THROMBOSIS JOURNAL (2021)

Add to Collection

Review Hematology

Plasminogen: an enigmatic zymogen

Charithani B. Keragala et al.

Summary: Plasminogen and plasmin play important roles not only in fibrinolysis but also in various physiological processes such as wound repair and modulation of cell behavior. The use of antifibrinolytic agents to reduce bleeding may have additional clinically relevant consequences, particularly in reducing infection risk. The broadening role of the plasminogen-activating system in physiology and pathophysiology suggests that manipulation of this system may have benefits unrelated to its conventional application in thrombosis and hemostasis.

BLOOD (2021)

Add to Collection

Article Medicine, Research & Experimental

Plasmin drives burn-induced systemic inflammatory response syndrome

Breanne H. Y. Gibson et al.

Summary: Severe injury induces systemic inflammatory response syndrome (SIRS), with early activation of plasmin playing a key role in driving SIRS. Plasmin activation is associated with injury severity, SIRS, coagulopathy, and mortality. Targeted inhibition of plasmin activation may be effective in limiting both hemorrhage and tissue-damaging inflammation after injury.

JCI INSIGHT (2021)

Add to Collection

Article Medicine, General & Internal

Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19

Lukas Infanger et al.

Summary: The study found strong correlations between parameters obtained by ClotPro and ROTEM Delta, but weaker correlations in intrinsically activated clotting times, indicating the need for device-specific algorithms in this patient cohort.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Cell Biology

Low level of plasminogen increases risk for mortality in COVID-19 patients

David Della-Morte et al.

Summary: This study found a significant association between low plasminogen levels and inflammatory markers, coagulation markers, and organ dysfunction markers in COVID-19 patients. Plasminogen may play a vital role in controlling the complex mechanisms behind the complications of COVID-19, serving as both a biomarker for prognosis and a potential therapeutic target.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Hematology

Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity

Mehmet Gokhan Gonenli et al.

Summary: Identifying a hypercoagulable state in COVID-19 patients using ROTEM can help differentiate subsets at significant thrombotic risk, especially in severe cases. This approach may assist in personalized therapeutic strategies and improve clinical outcomes.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Plasminogen improves lung lesions and hypoxemia in patients with COVID-19

Y. Wu et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Hematology

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure

Luca Spiezia et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Surgery

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Franklin L. Wright et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Add to Collection

Article Hematology

Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

Janice Wang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Fibrinolysis and COVID-19: A plasmin paradox

Robert L. Medcalf et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis

Christophe Nougier et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Critical Care Medicine

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Jan Matthias Kruse et al.

CRITICAL CARE (2020)

Add to Collection

Article Hematology

Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease

Breanne H. Y. Gibson et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Review Hematology

The multifaceted role of fibrinogen in tissue injury and inflammation

James P. Luyendyk et al.

BLOOD (2019)

Add to Collection

Article Veterinary Sciences

Correlation of plasma coagulation tests and fibrinogenClauss with rotational thromboelastometry parameters and prediction of bleeding in dogs

Nathalie M. Enk et al.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)

Add to Collection

Article Clinical Neurology

Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke

Celina Ducroux et al.

STROKE (2018)

Add to Collection

Article Critical Care Medicine

Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator

Hunter B. Moore et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)

Add to Collection

Article Critical Care Medicine

Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin

Christopher D. Barrett et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)

Add to Collection

Review Hematology

Platelet-Mediated Modulation of Fibrinolysis

Claire S. Whyte et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)

Add to Collection

Review Biotechnology & Applied Microbiology

Inhibition of Fibrinolysis by Coagulation Factor XIII

Dingeman C. Rijken et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Add to Collection

Article Critical Care Medicine

Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator

Hunter B. Moore et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)

Add to Collection

Article Critical Care Medicine

Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin

Christopher D. Barrett et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)

Add to Collection

Article Hematology

Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy

Antonia Sambola et al.

THROMBOSIS AND HAEMOSTASIS (2016)

Add to Collection

Article Hematology

Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow

Claire S. Whyte et al.

BLOOD (2015)

Add to Collection

Article Hematology

Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease

David Faraoni et al.

BLOOD COAGULATION & FIBRINOLYSIS (2015)

Add to Collection

Article Hematology

Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients

H. B. Moore et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Add to Collection

Article Multidisciplinary Sciences

Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography

Mauro Panigada et al.

PLOS ONE (2015)

Add to Collection

Review Hematology

PAI-1, progress in understanding the clinical problem and its aetiology

Takayuki Iwaki et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Add to Collection

Article Hematology

The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and α2-antiplasmin dependent

Vance G. Nielsen

BLOOD COAGULATION & FIBRINOLYSIS (2010)

Add to Collection

Article Hematology

Acute cigarette smoke exposure reduces clot lysis - association between altered fibrin architecture and the response to t-PA

Rajat S. Barua et al.

THROMBOSIS RESEARCH (2010)

Add to Collection

Article Anesthesiology

Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo

M. Mittermayr et al.

BRITISH JOURNAL OF ANAESTHESIA (2008)

Add to Collection

Article Hematology

Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation

Seiji Madoiwa et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)

Add to Collection

Article Hematology

Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans

AO Spiel et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Add to Collection

Article Multidisciplinary Sciences

Polyphosphate modulates blood coagulation and fibrinolysis

SA Smith et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Add to Collection

Review Hematology

The interactions between inflammation and coagulation

CT Esmon

BRITISH JOURNAL OF HAEMATOLOGY (2005)

Add to Collection

Article Physiology

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

P Prabhakaran et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)

Add to Collection

Article Critical Care Medicine

Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock

AC Mavrommatis et al.

INTENSIVE CARE MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.